Issue 30
Get instant access to latest e-book

latest news


Apr 2018

Biogen and Ionis Expand Strategic Collaboration to Develop Drug Candidates for a Broad Range of Neurological Diseases

Biogen and Ionis Pharmaceuticals announced they have expanded their strategic collaboration through a new tenyear collaboration agreement to develop novel antisense drug candidates for a broad range of neurological diseases This collaboration capitalizes on Biogens expertise in neuroscience research and drug development and Ionis leadership…


Apr 2018

Tocagen and ApolloBio Enter License Agreement to Develop and Commercialize Toca 511 & Toca FC

Tocagen Inc a clinicalstage cancerselective gene therapy company and Beijing Apollo Venus Biomedical Technology Limited an affiliate of ApolloBio Corp NEEQ a biopharmaceutical company focused on oncology collectively ApolloBio today announced they have entered into a license agreement providing ApolloBio with an exclusive license to…


Apr 2018

bioGO™ Introduces 'BioProduction Agility' to Accelerate Biotech Innovation

Germfree has released bioGO this week in New York at INTERPHEX The biomanufacturing platform represents a completely new approach to quick and flexible production space The company created bioGO in response to limited and rigid infrastructure options for launching biopharmaceutical projects The Adaptive Platform delivers…

press releases


Apr 2018

Merck Foundation and Tata Memorial Centre Signs MoU to Build Cancer Care Capacity in Africa

Business Wire IndiaDr Rasha Kelej CEO of Merck Foundation with the future oncologists of Africa getting trained at the Tata Memorial Centre in MumbaiDr Rasha Kelej CEO Merck Foundation and…


Apr 2018

Iterum Therapeutics Presents Data on Prevalence of Resistant Infections and Activity of its Novel Antibiotic Sulopenem

Iterum Therapeutics plc a clinicalstage pharmaceutical company developing antiinfectives against multidrug resistant pathogens will deliver a minioral presentation and two additional posters at the European Congress of Clinical Microbiology in…


Apr 2018

Phenomenex Introduces bioZen™ Series for Characterization of Biotherapeutics

Phenomenex Inc a global leader in the research and manufacture of advanced technologies for the separation sciences introduces bioZen a new series of LC solutions for bioseparations in pharmaceutical biopharmaceutical…

Events


Apr 2018

Vaccine Manufacturing 2018

KNect365 Life Science
Amsterdam RAI Exhibition and Convention Centre


  • 1

    Cancer Stem Cell (CSC) Inhibitors

    Cancer as a group of heterogeneous diseases very well known Unimaginable amounts of money and manhours have been spent in finding cure for this deadly disease H..
  • 6

    Mesoporous Silica Nanoparticles

    Mesoporous Silica Nanoparticles MSNs have attracted great attention over the last decade as a drug delivery system in the fields of biotechnology and Nano medic..

Knowledge Bank

  • Interviews

    European Lead Factory

    Head of European Screening Centre
    Ton Rijnders is the Head of Screening at the European Lead Factory He holds a PhD in molecular biology and has an extensive experience with drug discovery in pharma with increasing managerial and scientific responsibilities Since November Ton is the..

  • Articles

    Cancer Stem Cell (CSC) Inhibitors

    Cancer as a group of heterogeneous diseases very well known Unimaginable amounts of money and manhours have been spent in finding cure for this deadly disease Howeverit still remains in the top five list of diseases affecting mankind Millions of patients suffer worldwide every single day hoping to get cured Most of them lose…

Editorial Section

  • Strategy


    As the pharmaceutical industry squares off against the challenge of globalisation there is a greater need for content than ever Driven by forces from both the clinical and commercial sides pharmaceutical companies are experiencing rising costs and competition Ultimately to…

  • Research development

    Knowing vs Hunting for Targets

    Selecting a target for settingup the drug discovery path is a tough decision and often this choice is based on borrowed and incomplete knowledge from the literature In many cases this has led to serious challenges in the late stages…

  • Clinical Trials

    Use of Real World Evidence

    Real World Evidence RWE can be used to inform decisions throughout the life cycle of a drug from development through postapproval Across Asia many countries have begun incorporating real world evidence and while some are fast adopters in terms of…

  • Manufacturing

    Cultural Excellence as the Foundation

    In pharmaceutical companies it is universally understood that a robust Pharmaceutical Quality System PQS provides key elements of assurance and oversight for pharmaceutical manufacturing and quality control laboratory processes However despite recent advances in the…

  • Expert Talk

    Pushing the Limits of Temperature Control

    Todays pharmaceutical environment has become increasingly complex with more specialty products like biologics injectable and clinical trial drugs being shipped than ever The industry standard for commercial packaging is hours which is no longer always…